SGLT2 Inhibitors Lead to Favorable Renal, CV Outcomes in Type 2 Diabetes
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
Researchers studied the effect of dietary L-arginine on the incidence of type 2 diabetes.
Patients with severe asthma with low baseline cytokine levels responded well to benralizumab therapy.
A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
The AHA outlines screening, diagnosis, and treatment recommendations for obstructive sleep apnea and CV complications tied to the sleep disorder.
At AAD VMX 2021, researchers presented data on skin clearance rates through 5 years with guselkumab in patients with moderate to severe plaque psoriasis.
Patient-reported outcomes are a more sensitive measure than NYHA functional class for assessing changes in health status in HFrEF.
Nearly half of patients in the dupilumab arms achieved all 3 clinically meaningful endpoints in the phase 3 LIBERTY AD PEDS trial.
Study authors discuss recent advances in the interventional management of neuropathic pain; new therapies are needed to offer longitudinal and sustained management.
Supraspinal augmentation of sensory input, including sound, may represent a hallmark of fibromyalgia.